Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd. > The Stockhouse Publication ++ Todays News
View:
Post by PowerofNow on Aug 26, 2020 11:10am

The Stockhouse Publication ++ Todays News

SHOULD put us back to the mid .30's at the very least. If it were not for the impatient day traders this stock already before todays halt & news -- .50+. BUCILLAMINE has already been proven to combat Covid-19.... with that being said the orally disolved mushroom film is worth millions !!
Comment by itwillbeoknowok on Aug 26, 2020 11:14am
This post has been removed in accordance with Community Policy
Comment by PowerofNow on Aug 26, 2020 11:17am
The Good News as well is that the FDA has these approvals on a fast track progression. Once the trial is over, if proven to be useful the drug then will start getting more attention it deserves. Before you state you don't think just take 10 minutes to read doctors testimonials about the drug and its relation to the new world virus
Comment by pinkfloyd90 on Aug 26, 2020 11:20am
we need a buyout. the U.S. will issue the vaccine to an American company.
Comment by Trippedstocks on Aug 26, 2020 11:33am
isn't their new EUA for plasma from a UK company? Trump doesn't care where it comes from as long as it makes him look good.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities